Miriam Provost - 22 Feb 2022 Form 4 Insider Report for TransMedics Group, Inc. (TMDX)

Role
VP of Global Regl. Affairs
Signature
By: /s/ Stephen Gordon, Attorney-in-Fact
Issuer symbol
TMDX
Transactions as of
22 Feb 2022
Net transactions value
$0
Form type
4
Filing time
24 Feb 2022, 16:47:47 UTC
Previous filing
28 Dec 2021
Next filing
13 Dec 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TMDX Stock Option (Right to Buy) Award $0 +38,000 $0.000000 38,000 22 Feb 2022 Common Stock 38,000 $13.28 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 22, 2026.